Mirlet7d has also been reported to inhibit anti-inflammatory cytokines such as IL10 and IL13 (Su et al., 2021), and therefore may play a role in the upregulation of inflammatory response in the WAS rats. Here, IL13 is linked to Wiskott-Aldrich syndrome.